These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia. Sourek K; Tovarys F Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741 [No Abstract] [Full Text] [Related]
23. Three cases of terminal stage malignant gliomas in which the diffusely disseminated intraventricular tumors became the target of boron neutron capture therapy. Montagno Ede A; Moreira Filho L; Hatanaka H Strahlenther Onkol; 1989; 165(2-3):238-40. PubMed ID: 2494740 [No Abstract] [Full Text] [Related]
24. Harwell research on beams for neutron capture therapy. Constantine G; Gibson JA; Harrison KG; Schofield P Strahlenther Onkol; 1989; 165(2-3):92-5. PubMed ID: 2494754 [No Abstract] [Full Text] [Related]
25. Integrated approach in the planning of neutron capture therapy. Ryabukhin YS Strahlenther Onkol; 1989; 165(2-3):158-62. PubMed ID: 2494721 [No Abstract] [Full Text] [Related]
26. Research reactor adaptation project for neutron capture therapy. Sauer IL; de Souza JA; Montagno Ede A; Hatanaka H Strahlenther Onkol; 1989; 165(2-3):81-3. PubMed ID: 2494750 [No Abstract] [Full Text] [Related]
27. Enhanced survival in a rat glioma model following BNCT. Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736 [No Abstract] [Full Text] [Related]
29. Canine spontaneous brain tumors--a large animal model for BNCT. Gavin PR; Kraft SL; Wendling LR; Miller DL Strahlenther Onkol; 1989; 165(2-3):225-8. PubMed ID: 2494737 [No Abstract] [Full Text] [Related]
30. Boron determination for neutron capture therapy by colorimetry and emission spectrometry. Strouf O; Mertenová E; Schneiderová L; Zámecníková H; Janků I Strahlenther Onkol; 1989; 165(2-3):174-6. PubMed ID: 2494723 [No Abstract] [Full Text] [Related]
31. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011). Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787 [TBL] [Abstract][Full Text] [Related]
32. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro. Ziegler W; Sauerwein W; Streffer C Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731 [No Abstract] [Full Text] [Related]
38. Measurement and analysis on neutron flux distributions in a heavy water phantom using the KUR neutron guide tube for BNCT. Kobayashi T; Ono M; Kanda K Strahlenther Onkol; 1989; 165(2-3):101-3. PubMed ID: 2494707 [No Abstract] [Full Text] [Related]
39. Boronated antibodies for neutron capture therapy. Abraham R; Müller R; Gabel D Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718 [No Abstract] [Full Text] [Related]
40. A method for calculating the absorbed dose near interface from 10B(n, alpha)7Li reaction. Kitao K Radiat Res; 1975 Feb; 61(2):304-15. PubMed ID: 803317 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]